SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RUZZA, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.472
AS - Asia 2.193
EU - Europa 1.461
SA - Sud America 431
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.602
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.393
SG - Singapore 959
CN - Cina 597
IT - Italia 396
BR - Brasile 353
DE - Germania 227
HK - Hong Kong 196
PL - Polonia 184
VN - Vietnam 158
GB - Regno Unito 144
UA - Ucraina 129
TR - Turchia 94
FI - Finlandia 90
RU - Federazione Russa 74
ID - Indonesia 49
SE - Svezia 47
CA - Canada 43
FR - Francia 43
AR - Argentina 33
IN - India 31
MX - Messico 27
BD - Bangladesh 26
NL - Olanda 22
ZA - Sudafrica 22
JP - Giappone 21
BE - Belgio 17
IE - Irlanda 17
EC - Ecuador 15
ES - Italia 15
AT - Austria 13
CZ - Repubblica Ceca 12
LT - Lituania 12
IQ - Iraq 11
PK - Pakistan 8
VE - Venezuela 8
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
PE - Perù 6
CO - Colombia 5
SA - Arabia Saudita 5
KZ - Kazakistan 4
TN - Tunisia 4
UY - Uruguay 4
BG - Bulgaria 3
CH - Svizzera 3
DK - Danimarca 3
IL - Israele 3
KW - Kuwait 3
NP - Nepal 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GY - Guiana 2
IR - Iran 2
JO - Giordania 2
KR - Corea 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
PH - Filippine 2
PY - Paraguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
JM - Giamaica 1
KG - Kirghizistan 1
LU - Lussemburgo 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
ZW - Zimbabwe 1
Totale 8.602
Salva come PNG Salva come JPEG
Città #
Ashburn 623
Singapore 514
Fairfield 498
Woodbridge 401
Santa Clara 256
Beijing 240
Houston 235
Seattle 217
Cambridge 194
Hong Kong 194
Ann Arbor 183
Wilmington 183
Warsaw 178
Chandler 161
Jacksonville 153
Ferrara 147
Los Angeles 94
Munich 87
New York 76
Shanghai 62
Dallas 59
Ho Chi Minh City 59
Princeton 57
Milan 56
Izmir 53
Nanjing 44
Jakarta 38
Bologna 37
London 35
São Paulo 34
San Diego 32
Dearborn 31
Helsinki 31
Chicago 28
Turku 28
Boardman 27
Hanoi 27
Frankfurt am Main 21
Atlanta 20
Tokyo 18
Brooklyn 17
Mexico City 17
Belo Horizonte 16
Brussels 16
Dublin 16
Falkenstein 16
Addison 15
Denver 14
Moscow 14
Nanchang 14
Buffalo 13
Hefei 13
Johannesburg 13
Montreal 13
Shenyang 13
Toronto 13
Assago 12
Falls Church 12
Norwalk 12
Phoenix 12
Rio de Janeiro 12
Tianjin 12
Orem 11
Padova 11
Stockholm 11
Brasília 10
Guangzhou 10
Bremen 9
Chennai 9
Manchester 9
San Francisco 9
Da Nang 8
Nuremberg 8
Poplar 8
Porto Alegre 8
Redwood City 8
Vienna 8
Washington 8
Boston 7
Changsha 7
Guayaquil 7
Hebei 7
Olomouc 7
The Dalles 7
Bari 6
Bexley 6
Dhaka 6
Ferrara di Monte Baldo 6
Jiaxing 6
Mountain View 6
Mumbai 6
Nairobi 6
Roubaix 6
Tashkent 6
Ankara 5
Auburn Hills 5
Augusta 5
Biên Hòa 5
Charlotte 5
Curitiba 5
Totale 6.013
Salva come PNG Salva come JPEG
Nome #
Pharmacological and neurobiological studies on Neuropeptide S and its receptor 227
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 217
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 205
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 201
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 200
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 195
Modulation of the NOP receptor signaling affects resilience to acute stress 192
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 188
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 185
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 185
Pharmacological characterization of tachykinin tetrabranched derivatives 185
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 184
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 175
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 172
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 168
Neuropeptide S receptor ligands: a patent review (2005-2016) 168
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 166
Structure-activity study at positions 3 and 4 of human neuropeptide S. 164
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 164
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 164
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 162
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 161
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 154
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 153
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 153
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 152
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 148
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 145
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 140
NOP agonist action of cebranopadol counteracts its liability to promote physical dependence 134
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 123
NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine 122
The concise guide to pharmacology 2021/22: G protein-coupled receptors 118
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors 116
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 115
Novel Mixed NOP/Opioid Receptor Peptide Agonists 114
Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test 112
null 110
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders 107
null 105
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 103
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 102
NOP Ligands for the Treatment of Anxiety and Mood Disorders 95
Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040 95
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics 91
Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice 91
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 90
Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress 90
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test 89
null 87
Pharmacological characterization of naloxegol: In vitro and in vivo studies 86
Preclinical effects of cannabidiol in an experimental model of migraine 83
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 81
The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus 79
null 77
Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling 75
Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice 73
In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay 71
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 70
Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis 69
The concise guide to pharmacology 2019/20: G protein-coupled receptors 69
Effects of Stress Exposure to Pain Perception in Pre-Clinical Studies: Focus on the Nociceptin/Orphanin FQ-NOP Receptor System 65
Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors 63
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 63
Pharmacology, physiology and genetics of the neuropeptide s system 61
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors 52
Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo 52
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop 50
null 42
Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress 42
Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice 39
Sex differences in response to NLRP3 inflammasome blockage in a mouse migraine model: A genetic and pharmacological study 33
Nociceptin/OrphaninFQ Receptor Modulates the Maturation of Adult-Born Neurons in the Mouse Dentate Gyrus Under Physiological Conditions and in a Chronic Stress Model 28
An Insight into Neuronal Processing of Ghrelin: Effects of a Bioactive Ghrelin Derivative on Proteolytic Pathways and Mitophagy 28
The concise guide to pharmacology 2017/18: Overview 23
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 14
Totale 8.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 710
Totale 46.766
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021491 0 0 0 0 0 81 66 78 41 102 74 49
2021/2022524 33 35 28 39 37 38 27 41 24 52 35 135
2022/2023455 58 42 23 48 58 44 39 37 50 5 27 24
2023/2024427 32 47 25 14 26 78 22 39 4 21 14 105
2024/20251.682 43 43 153 73 191 177 16 73 293 169 238 213
2025/20262.728 562 274 407 619 806 60 0 0 0 0 0 0
Totale 8.770